Bartlett & Co’s Kindred Healthcare KND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,080
Closed -$14K 711
2017
Q3
$14K Hold
2,080
﹤0.01% 559
2017
Q2
$24K Hold
2,080
﹤0.01% 514
2017
Q1
$17K Hold
2,080
﹤0.01% 557
2016
Q4
$16K Hold
2,080
﹤0.01% 563
2016
Q3
$21K Hold
2,080
﹤0.01% 541
2016
Q2
$23K Hold
2,080
﹤0.01% 540
2016
Q1
$26K Hold
2,080
﹤0.01% 505
2015
Q4
$25K Hold
2,080
﹤0.01% 517
2015
Q3
$33K Hold
2,080
﹤0.01% 478
2015
Q2
$42K Hold
2,080
﹤0.01% 457
2015
Q1
$49K Hold
2,080
﹤0.01% 435
2014
Q4
$38K Hold
2,080
﹤0.01% 470
2014
Q3
$40K Hold
2,080
﹤0.01% 458
2014
Q2
$48K Buy
+2,080
New +$50.8K ﹤0.01% 447
2014
Q1
Sell
-4
Closed 730
2013
Q4
$0 Hold
4
﹤0.01% 799
2013
Q3
$0 Hold
4
﹤0.01% 876
2013
Q2
$0 Buy
+4
New +$48 ﹤0.01% 731

Other funds holding KND

Bartlett & Co's KND Position: Q4 2017 in Review

Bartlett & Co sold out of Kindred Healthcare (KND) in Q4 2017, closing a stake of 2,080 shares — an estimated $14K sold.

Bartlett & Co first reported a position in KND in Q2 2013 and held it in 17 quarters. The position peaked at $49K in Q1 2015. 181 funds tracked by Wall St. Rank hold KND as of Q4 2017.

  • Bartlett & Co reported no remaining Kindred Healthcare position as of Q4 2017 after selling out during the quarter.
  • Bartlett & Co sold 2,080 Kindred Healthcare shares in Q4 2017, an estimated $14K.
  • Bartlett & Co first reported a position in Kindred Healthcare in Q2 2013 and held it in 17 quarters.
  • Bartlett & Co's Kindred Healthcare position peaked at $49K in Q1 2015.
  • 181 funds tracked by Wall St. Rank held Kindred Healthcare as of Q4 2017.

Based on Bartlett & Co's 13F filing for Q4 2017, filed 19 Jan 2018.